We are live on ! Find out more
BCA

Berman Capital Advisors Portfolio holdings

AUM $636M
1-Year Est. Return 30.04%
This Fund
S&P 500
This Quarter Est. Return
+8.75%
1 Year Est. Return
+30.04%
3 Year Est. Return
+49.34%
5 Year Est. Return
10 Year Est. Return
AUM
$352M
AUM Growth
-$28.8M
Cap. Flow
-$56M
Cap. Flow %
-15.91%
Top 10 Hldgs %
56.37%
Holding
1,884
New
135
Increased
547
Reduced
526
Closed
132

Sector Composition

Rank Sector Weight
1 Technology 7.36%
2 Financials 4.95%
3 Consumer Discretionary 3.87%
4 Healthcare 3.34%
5 Communication Services 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRUS icon
1026
Cirrus Logic
CRUS
$6.53B
$5K ﹤0.01%
87
CSL icon
1027
Carlisle Companies
CSL
$15.3B
$5K ﹤0.01%
46
+7
+18% +$859
DECK icon
1028
Deckers Outdoor
DECK
$13.5B
$5K ﹤0.01%
144
EDU icon
1029
New Oriental
EDU
$9.06B
$5K ﹤0.01%
35
-2
-5% -$289
ERIE icon
1030
Erie Indemnity
ERIE
$13.1B
$5K ﹤0.01%
24
FL
1031
DELISTED
Foot Locker
FL
$5K ﹤0.01%
158
FLR icon
1032
Fluor
FLR
$7.2B
$5K ﹤0.01%
574
FRPT icon
1033
Freshpet
FRPT
$3.51B
$5K ﹤0.01%
45
FVD icon
1034
First Trust Value Line Dividend Fund
FVD
$8.37B
$5K ﹤0.01%
+180
New +$5.71K
GNTX icon
1035
Gentex
GNTX
$5.08B
$5K ﹤0.01%
231
HALO icon
1036
Halozyme
HALO
$9.87B
$5K ﹤0.01%
202
HCSG icon
1037
Healthcare Services Group
HCSG
$1.57B
$5K ﹤0.01%
270
HUN icon
1038
Huntsman Corp
HUN
$1.78B
$5K ﹤0.01%
257
IMMR icon
1039
Immersion
IMMR
$255M
$5K ﹤0.01%
795
IONS icon
1040
Ionis Pharmaceuticals
IONS
$9.01B
$5K ﹤0.01%
111
+91
+455% +$5.05K
IOVA icon
1041
Iovance Biotherapeutics
IOVA
$1.94B
$5K ﹤0.01%
172
IPGP icon
1042
IPG Photonics
IPGP
$3.9B
$5K ﹤0.01%
35
J icon
1043
Jacobs Solutions
J
$16.9B
$5K ﹤0.01%
73
JAZZ icon
1044
Jazz Pharmaceuticals
JAZZ
$17B
$5K ﹤0.01%
37
+5
+16% +$620
LMAT icon
1045
LeMaitre Vascular
LMAT
$1.81B
$5K ﹤0.01%
177
LPL icon
1046
LG Display
LPL
$3.26B
$5K ﹤0.01%
883
MANH icon
1047
Manhattan Associates
MANH
$11.2B
$5K ﹤0.01%
55
NRG icon
1048
NRG Energy
NRG
$25.5B
$5K ﹤0.01%
197
-117
-37% -$3.87K
NTAP icon
1049
NetApp
NTAP
$36.6B
$5K ﹤0.01%
125
-20
-14% -$873
PCRX icon
1050
Pacira BioSciences
PCRX
$991M
$5K ﹤0.01%
+85
New +$4.94K

Similar funds

Berman Capital Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Berman Capital Advisors held 1,884 positions worth $352M, down 7.6% from $381M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Berman Capital Advisors withdrew a net $56M in Q3 2020, closing 132 positions and reducing 526 holdings. Its most notable exit was iShares Core S&P Total US Stock Market ETF, an estimated $18.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, up from 6.5% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Berman Capital Advisors opened a new position in Snowflake worth $251K.

  • Berman Capital Advisors's largest Q3 2020 buy was Snowflake: 1,000 shares worth $251K.
  • Berman Capital Advisors added most to Berkshire Hathaway Class B in Q3 2020, an estimated $1.56M increase.
  • Berman Capital Advisors's biggest Q3 2020 reduction was Vanguard Total Bond Market, cutting an estimated $19.9M.
  • Berman Capital Advisors fully exited iShares Core S&P Total US Stock Market ETF in Q3 2020, selling an estimated $18.6M.
  • Berman Capital Advisors's ten largest holdings make up 56% of its $352M portfolio in Q3 2020.
  • Berman Capital Advisors opened 135 new positions and closed 132 in Q3 2020.
  • Berman Capital Advisors's portfolio value fell 7.6% quarter-over-quarter to $352M.

Based on Berman Capital Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.